ECHO PITCH 2022

ECHO Pitch 2022

Join us October 13, 2022 for ECHO PITCH: a special event where five top cardiovascular health start-ups compete for funding from a $250,000 pool in front of a panel of judges and a live audience.

These five finalists have been selected from the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program, where they received 12 months of hands-on entrepreneurship training and mentorship.

Event Details

  • What: ECHO PITCH 2022
  • When: Thursday, October 13, 2022
  • Time: 3 – 8:00 p.m. EST
  • Where: Malaparte – TIFF Bell Lightbox – 350 King St. W., 6th Floor

What can you expect?

  • Watch five inspiring innovators of cardiovascular technologies pitch their novel ideas.
  • Meet, connect and share ideas with exceptional entrepreneurs, scientist, clinicians, business leaders and investors.
  • Gain insights from a multi-sectoral panel of judges as well as expert keynote speakers.
  • Enjoy an afternoon of entertainment, food and beverages.

Join us to learn, network, and set your entrepreneurial spirit free! Hurry – space is limited.


Agenda

ECHO PITCH will feature five pitches, a keynote speaker, and a dinner reception and award presentation. Details to follow soon.

TimeDetails
3:00 – 3:30 PMRegistration & Networking
3:30 – 3:40 PMIntroductions
Dr. Soror Sharifpoor
Director-Strategy & Translation, Translational Biology and Engineering Program, University of Toronto, Ted Rogers Centre for Heart Research
Prof. Timothy Chan
Associate Vice-President and Vice-Provost, Strategic Initiatives, University of Toronto
Dr. Mansoor Husain
Executive Director, Ted Rogers Centre for Heart Research
3:40 – 4:10 PMFireside Chat
Mr. Kris Shah
President, Baylis Medical Technologies
Prof. Paul Santerre
Professor of Biomaterials, University of Toronto
Baxter Chair for Health Technology and Commercialization, University Health Network
Co-Director, Health Innovation Hub (H2i)
4:10 – 4:55 PMPitch Competition – Session 1
Dr. Soror Sharifpoor
Director-Strategy & Translation, Translational Biology and Engineering Program, University of Toronto, Ted Rogers Centre for Heart Research
Pitch-1: Balliscor
Pitch-2: Flora Bioworks
4:55 – 5:15 PMBreak
5:15 – 6:15 PMPitch Competition – Session 2
Pitch-3: Magellan Biomedical
Pitch-4: VitalTracer
Pitch-5: Vitresonic
6:15 – 6:45 PMKeynote Presentation
Dr. Matthew Banet
President, Sibel Health
6:45 – 8:00 PMDinner Reception & Award Presentation
Prof. Craig Simmons
Scientific Lead, Translational Biology and Engineering Program, University of Toronto, Ted Rogers Centre for Heart Research
8:00 PMProgram Close


Fireside Chat

ECHO PITCH 2022 will feature an intimate session with Kris Shah, President of Baylis Medical Technologies.

Kris Shah

Kris Shah

President, Baylis Medical Technologies

View Bio

Keynote Address

Matthew Banet

Matthew Banet, PhD

President, Sibel Health

View Bio

ECHO Start-up Finalists

Congratulations to the five companies in our 2021-22 ECHO program that made it to this final stage. They are:

ECHO Judging Panel

Dozie Amuzie

Dozie Amuzie, DVM, PhD, DACVP, DABT

Head, Johnson & Johnson Innovation – JLABS Canada

View Bio
Matthew Banet

Matthew Banet, PhD

President, Sibel Health

View Bio
Jacki Jenuth

Jacki Jenuth, PhD

Partner, Lumira Ventures

View Bio
Seema Mital

Seema Mital, MD, FACC, FAHA, FRCPC

Professor of Pediatrics, University of Toronto
Staff Cardiologist and Head of Cardiovascular Research, Hospital for Sick Children
Senior Scientist, SickKids Research Institute
Heart and Stroke Foundation of Canada Chair in Cardiovascular Science
Scientific Co-Lead, Ted Rogers Centre for Heart Research

View Bio
Kris Shah

Kris Shah

President, Baylis Medical Technologies

View Bio
Pitch presentation during our inaugural competition


About ECHO

ECHO is a specialized hands-on training program led by veteran entrepreneurs and consultants across a variety of sectors. Its mission:

(1)   Provide innovators of cardiovascular technologies with entrepreneurship training, mentorship, networking and funding opportunities;

(2)   Transfer research innovations and intellectual property from academic and hospital institutions into the economy;

(3)   Create more start-ups in the Canadian cardiovascular health sector.

ECHO is funded and organized by the Translational Biology and Engineering Program, at the University of Toronto and the Ted Rogers Centre for Heart Research, in partnership with the Health Innovation Hub.